Limitations of the p16-3MR mouse model for detecting and eliminating senescent cells
Abstract The p16-3MR mouse model, designed to express Renilla luciferase, mRFP, and herpes simplex virus 1 thymidine kinase (HSV-TK) under the p16 INK4a promoter, has been widely used to visualize and ablate senescent cells in vivo, but our analyses revealed critical limitations. Bioluminescence signals in p16-3MR mice were extremely weak and virtually indistinguishable from those of wild-type mice injected with coelenterazine-h, indicating that previously reported signals largely reflected substrate background rather than authentic reporter expression. Signal intensity remained unchanged with aging, doxorubicin treatment, or cutaneous wound healing, failing to replicate earlier observations. Furthermore, RFP signals were undetectable in senescent fibroblasts from p16-3MR mice, and senescent cells were not eliminated by ganciclovir treatment, suggesting poor expression and lack of functional activity of the mRFP and HSV-TK transgenes. These results demonstrate functional deficiencies in all three transgenes, highlighting the importance of using wild-type controls and calling for careful reevaluation of studies employing this system.
Authors
- Daisuke Motooka (ORCID: https://orcid.org/0000-0002-4616-9608)
- Ken Uemura
- Yumi Kinugasa‐Katayama
- Naoko Ohtani (ORCID: https://orcid.org/0000-0001-8934-0797)
- Shimpei Kawamoto (ORCID: https://orcid.org/0000-0002-7033-671X)
- Masahiro Wakita
- Yumiko Okumura
- Nozomi Hori
- Jeong Hoon Park
- Eiji Hara (ORCID: https://orcid.org/0000-0001-7821-3960)
- Kentaro Tanaka
Institutions
- Tokyo Metropolitan University (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- EMBO Reports
- Published
- 2026-05-28
- DOI
- https://doi.org/10.1038/s44319-026-00802-8
- Citations
- 1
- Primary Topic
- Telomeres, Telomerase, and Senescence
- Type
- article
- Field-Weighted Citation Impact
- 13.83
Funders
- Takeda Science Foundation
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science London
- Ministry of Education, Culture, Sports, Science and Technology
- Mitsubishi Foundation
- Astellas Pharma
- Astellas Foundation for Research on Metabolic Disorders
- Princess Takamatsu Cancer Research Fund
- Foundation for Biomedical Research and Innovation
- Lotte Foundation
- Chugai Pharmaceutical
- Japan Society for the Promotion of Science
- Japan Science and Technology Agency